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The purpose of this study was to investigate the short-term of Thera-
curmin dose and exercise type on pain, walking ability, and muscle 
function in patients with knee osteoarthritis. Twenty-five patients with 
knee osteoarthritis randomly selected to Theracurmin intake (T) group 
and Theracurmin in combined with exercise (T+E) group. T group 
(n= 13) was taken orally a capsule of 700 mg, 3 times per day, (total 2,100 
mg, 35 mg/kg-body weight). T+E group (n= 12) performed aerobic train-
ing of 30-min walking and weight training for increasing leg muscular 
strength. After treatment, the number of steps, muscle mass, range of 
motion of knee, and the muscle strength in flexion and extension signifi-
cantly increased. The percent body fat, visual analogue scale, The 
Western Ontario and McMaster score, centers of pressure with closed 
eye, 10-m walking ability, stair ascending speed were significantly de-
creased after treatment. Although no difference observed between the 
T and T+E groups, the 4-week intake of Theracurmin with and without 
exercise appeared to be effective in reducing the pain and enhancing 
muscular and balancing function. Therefore, Theracurmin intake for 
early symptoms and additional exercise as symptoms alleviate might be 
an effective way of delaying and managing osteoarthritis, and addition-
al studies investigating the effects of Theracurmin and exercise on os-
teoarthritis could be beneficial.
Keywords: Theracurmin, Exercise, Pain, Walking ability, Knee osteoar-
thritis
INTRODUCTION
Osteoarthritis, also known as degenerative joint disease, gradu-
ally destroys the joints over time. The biochemical cause of osteo-
arthritis is still not entirely clear, but it has been reported that 
matrix metalloproteinases (MMPs) are involved in the degrada-
tion process of cartilage tissue. MMPs are excessively generated 
when the joint structure is abnormal or when an abnormally strong 
mechanical or biochemical stimulus acts on the articular cartilage 
tissue (Henrotin et al., 2002).
Osteoarthritis is more likely to occur with increasing age (Cross 
et al., 2014; Felson et al., 2000). Patients with osteoarthritis suffer 
from symptoms such as joint pain, decreased daily living function, 
joint deterioration, and gait deviation (Franklin et al., 2008; Guc-
cione et al., 1994). Osteoarthritis mainly causes pain due to loss and 
degeneration of cartilage tissue that functions to prevent friction 
and absorb impact (Davies et al., 2008). Loss and degeneration of 
cartilage tissue thus results in a decrease in walking speed and 
knee joint working range and limits daily living function. These 
changes eventually lead to diminished muscular strength and bal-
ance control from weakened muscles surrounding the knee joint 
(Hong, 2007). Therefore, rehabilitation treatment programs for 
osteoarthritis patients must be a combination of methods that de-
crease pain and stress on the joint and improve muscular function.
Most previous studies reported that aerobic exercises like walk-
ing and weight training (for strengthening the quadriceps femoris 
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muscle) are effective in decreasing pain and improving muscular 
function (Jordan et al., 2003; Roddy et al., 2005). Osteoarthritis is 
most common in the knee joint. Osteoarthritis involves inflamma-
tion and decreased function of not only the cartilage of the knee but 
also the muscles, tendons, ligaments, and synovia of the knee; there-
fore, it is challenging for osteoarthritis patients to perform the train-
ing treatment without pain management (Aigner et al., 2006).
Pain is caused by direct stimulation of pain receptors that trig-
gers an inflammation mediator or by secondary inflammation 
from biochemical or autoimmune responses. Therefore, the most 
common treatment for decreasing the pain of osteoarthritis has 
been the administration of analgesic and nonsteroidal anti-inflam-
matory drugs. However, these drugs can cause severe gastrointes-
tinal and cardiovascular adverse events with long-term use (Felson 
et al., 2000), and disease modifying agents that not only decrease 
the pain but also delay the progression of osteoarthritis would be 
beneficial. 
Curcumin is a yellow polyphenolic spice extracted from rhizomes 
of curcuma long a linn, a plant classified as in the ginger family 
and mainly used for cooking foods like curries. Recently it has 
been shown to have anti-inflammatory and antioxidative proper-
ties according to many studies (Goel et al., 2008; Vogel and Pel-
letier, 1815). It reported that curcumin regulates biochemical 
molecular mechanisms by controlling various molecular targets 
such as transcription factors, cytokines, and enzymes (Gupta et al., 
2012). These effects of curcumin are reported to be effective for 
diseases related to chronic inflammation such as cardiovascular 
disease, metabolic syndromes, osteoarthritis, and other aging re-
lated diseases (Goel et al., 2008; Gupta et al., 2012; Wongcharoen 
and Phrommintikul, 2009). Curcumin has also been reported to 
regulate osteoarthritis without any gastrointestinal adverse effects 
(Mobasheri et al., 2012).
Despite the many reports on the beneficial effects of curcumin, 
it has low bioavailability when taken orally and has a short half-
life. Therefore, a limited number of studies shows effects of oral 
curcumin taken by human subjects. Accordingly, a drug called 
Theracurmin recently developed with the physiologic activity of 
curcumin increased by 27 times, and it was reported that the pain 
of osteoarthritis patients significantly decreased after taking Ther-
acurmin for 8 weeks (Nakagawa et al., 2014). However, the stud-
ies on the effects of Theracurmin intake have yet to show consis-
tent results of significantly decreased pain or other significant im-
provements (Akazawa et al., 2012; Mathy-Hartert et al., 2009; 
Nakagawa et al., 2014). In addition, although previous studies 
involving treatment with Curcumin have demonstrated positive 
effects in decreasing pain, there have been no studies demonstrat-
ing an increase in functional capability. A study needs to be done 
demonstrating the effects of curcumin in conjunction with exer-
cise, which is the suggested rehabilitation treatment program for 
osteoarthritis patients.
Therefore, this study was to investigate the effects of Theracur-
min (Kyungdong market, Seoul, Korea) intake for reducing pain 
in conjunction with rehabilitation training for osteoarthritis af-
fects pain and muscular function of osteoarthritis patients.
MATERIALS AND METHODS
Subjects
Osteoarthritis patients with knee pain who visited Dream Han-
maum Rehabilitation Medicine located in Seoul, selected 25 pa-
tients satisfied the clinical and radiologic diagnostic criteria for 
knee joint osteoarthritis proposed by the Rheumatic Society (Alt-
man, 1991), and also satisfied the criteria for second to third de-
gree involvement on the Kellgren-Lawrence magnitude scale on 
more than one knee. The study was approved by the Institutional 
Ethnics Committee of Physical Education of the Dankook Uni-
versity (2015-05-001). Written informed consent obtained from 
all subjects. Patients with under drug treatment for other diseases, 
history of drug hypersensitivity reactions, and a swelling on their 
knee excluded from this study. All the selected patients were to 
provide informed consent before the start of the study. The final 
selected subjects randomly split into two groups (Theracurmin 
intake group, T group; Theracurmin with exercise group, T+E 
group) (Table 1). In addition, because changes in physical activity 
can affect the treatment, all subjects given a step-measuring in-
strument so that they could record daily steps during the treat-
ment period in addition to the exercise time. Changes in the 
number of steps described in Fig. 1. The number of steps during 
the treatment period significantly increased (F=4.713, P<0.05), 
with a tendency of correlation effect between the treatment and 
Table 1. Baseline demographic of the knee osteoarthritis patients according to 
the treatment
Variable T (n= 13) T+E (n= 12) Sig
Age (yr) 44.77± 5.38 40.58± 7.71 -1.583 0.127
Duration of knee pain (mo)   3.31± 1.18   4.08± 1.38 -1.191 0.246
Site of knee
   Right:left 6:7 8:4
   Grade   1.69± 0.63   1.41± 0.52 1.118 0.275
Values are presented as mean± standard deviation or number.
T, Theracurmin intake group; T+E, Theracurmin with exercise group.
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the groups (F=4.333, P=0.051), but there was no difference be-
tween the two groups. 
Body composition measurement
Every subject underwent anthropometric examination while 
wearing light clothes; data regarding medical history also collect-
ed. Body weight (BW) and body fat percentage measured using 
InBody (Inbody 4.5, Biospace, Seoul, Korea), and body mass in-
dex (BMI) calculated as weight (kg) divided by height (m). 
Pain test
Degree of pain for osteoarthritis patients was measured using a 
visual analogue scale (VAS), A translated contents of The Western 
Ontario and McMaster Universities Osteoarthritis index (WOM-
AC-VA3.0) verified by Yi et al. (2008) and Bellamy (1988) were 
used for this study. The survey included three major sections on 
pain, joint stiffness, and difficulty in physical function. The pain 
section had five questions, the joint stiffness section had two ques-
tions, and the difficulty in physical function section had 17 ques-
tions total. The questionnaire administered by a trained physical 
therapist after a face-to-face interview. 
Range of motion of knee test
Knee joint flexion angle measured with the patient lying down 
on the examination table with the leg flexed and bent voluntarily 
as much as possible at both, the right and left knee using a goni-
ometer. Knee joint extension angle measured with the patient ly-
ing with his/her face down on the examination table with a pillow 
underneath the thigh and the knee joint extended on both, the 
right and left knee using a goniometer. 
Balance test
The balance test involved examining the patient’s performance 
while standing on one leg under both conditions: centers of pres-
sure (COP) with the eyes open and eyes closed, and the perfor-
mance in the balance wobble test when standing. The durations 
for which the patient stood on one leg with the eyes open and eyes 
closed were measured in seconds, and the duration was considered 
till the time the lifted foot touched the ground or when the main-
taining foot moved more than twice. The balance wobble test ap-
plied while standing used to analyze the degree to which the pa-
tient’s balance shook, in millimeters, when he/she stood on the 
balance disk and when he/she stood on one leg. 
Walking ability test
The 10-m walking test and going up and down stairs that are 
similar to the daily activity of osteoarthritis patients performed as 
walking ability test. The 10-m walking test measured as the time 
in seconds that the subjects wearing comfortable shoes took to walk 
10 m as fast as possible after the “start” sign. In addition, a ground 
reaction plate installed on the 10 m straight course for measuring 
the weight loaded on the pelvis. Walking up and down stairs mea-
sured as the time in seconds the subjects took when walking up and 
down 10 stairs of 1.6-cm height in a row without running. 
Isokinetic strength test
Peak torque, total work, and average power of thigh measured 
using an isokinetic training instrument called Biodex (Biodex 
B-2000, Biodex Medical Systems Inc., Shirley, NY, USA). Sub-
jects were performed the procedure by repeating the warm-up ex-
ercise five times so that they could exhibit their maximum capaci-
ty. Gravity effect torque measured and analyzed to rule out the ef-
fect coming from the weight of the leg. Subjects sat on a flat chair 
seat, placed the knee joint axis parallel to the dynamometer axis, 
and fixed their upper body with a torso belt and seat belt to mini-
mize interference except for the quadriceps femoris muscle. The 
test repeated 5 times at 60°/sec to measure the maximum muscu-
lar strength and the total work amount, and the subjects were en-
couraged to demonstrate their maximum ability. 
Curcumin intake method
Curcumin intake was recommended to be ingested within the 
approved range of dosage by the Food and Drug Administration 
as “Generally Regarded As Safe” (0.1–3 mg/kg-BW, clinical de-
velopment plan) (Chemoprevention Branch and Agent Develop-
ment Committee, 1996). However, preliminary studies and dis-
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cussions suggested that this dosage might be too low for physio-
logic activity due to low intestinal absorption and short half-life 
of curcumin (Anand et al., 2007; Shoba et al., 1998). Other stud-
ies suggested a dosage of up to 12 g/day is safe for humans (Anand 
et al., 2007), with no side effects when 180 mg of Theracurmin 
was taken per day for 8 weeks (Nakagawa et al., 2014). Therefore, 
a capsule of 700 mg was taken orally 3 times per day, (total 2,100 
mg, 35 mg/kg-BW) (for a limited period of four weeks because of 
its high dosage) after consultation with experts.
Exercise training program
The exercise training program consisted of aerobic training of 
30-min walking and weight training for increasing leg muscular 
strength. Aerobic exercise started at 15 min on the first week; there-
after, it increased by 5 min every week so that in the last week, 
walking time reached 30 min. Weight training is composed of 
the movements for strengthening major muscles for the knee joint 
such as quadriceps femoris muscle, hamstrings, and triceps mus-
cle of calf muscle (Han and Bang, 1994). Stretching, pressing down 
on the knee with a towel, tightening the towel, and gym ball squats 
carried out 8–10 times each, 2 sets total, and 3 times per week 
during the adaptation period of the first 2 weeks. During the im-
provement period (3 and 4 weeks), squats on a chair, kicks on a 
chair, and standing on heels on a chair were performed again 8–10 
times each, 2 sets total, and 3 times per week. 
Statistical analysis
The statistical analyses performed using IBM SPSS ver. 18.0 
(IBM Co., Armonk, NY, USA). The data expressed as average and 
the standard deviation for each group. A two-way analysis of vari-
ance with repeated measures performed to verify the effect of the 
time and treatment. The statistically significant level (α) for all 
analysis was 0.05. 
Table 2. The changes of body composition after treatment
Variable Group Pre Post              Sig
Weight (kg) T 61.98± 5.28 61.91± 4.93 Time 0.601
T+E 62.61± 6.45 62.45± 6.56 Group 0.806
T× G 0.848
Muscle mass (kg) T 21.01± 2.24 21.68± 1.31 Time 0.049*
T+E 21.84± 2.42 22.19± 2.40 Group 0.424
T× G 0.531
%Fat (%) T 37.69± 5.19 35.47± 3.24 Time 0.045*
T+E 35.62± 3.70 34.45± 3.60 Group 0.275
T× G 0.520
Body mass index  
   (kg/m2)
T 25.55± 2.11 25.62± 1.96 Time 0.958
T+E 25.31± 2.67 25.23± 2.80 Group 0.748
T× G 0.463
Values are presented as mean± standard deviation.
T, Theracurmin intake; T+E, Theracurmin with exercise.
*P< 0.05.
Table 4. The changes of range of motion of knee after treatment
Variable Group Pre Post               Sig
More-pain site
Flextion (°) T 130.42± 6.45 135.58± 8.46 Time 0.000***
T+E 127.00± 8.79 134.00± 7.48 Group 0.398
T× G 0.458
Extension (°) T -11.08± 2.50 -9.50± 1.88 Time 0.001**
T+E -10.85± 3.58 -8.69± 3.40 Group 0.629
T× G 0.580
Less-pain site
Flextion (°) T 131.50± 5.99 138.42± 5.03 Time 0.000***
T+E 126.77± 8.70 135.15± 11.01 Group 0.104
T× G 0.517
Extension (°) T -12.83± 3.61 -10.33± 2.35 Time 0.000***
T+E -11.54± 2.15 -8.15± 2.91 Group 0.086
T× G 0.443
Values are presented as mean± standard deviation.
T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01. ***P< 0.001.
Table 3. The changes of pain score after treatment
Variable Group Pre Post             Sig
VAS (score) T 4.42± 1.16 2.75± 1.76 Time 0.000***
T+E 5.00± 1.87 3.08± 2.36 Group 0.474
T× G 0.751
WOMAC (score)
Pain T 5.25± 2.18 3.17± 2.41 Time 0.000***
T+E 6.38± 3.43 3.54± 3.26 Group 0.477
T× G 0.455
Joint stiffness T 2.25± 1.28 2.25± 1.48 Time 0.239
T+E 3.15± 1.95 34.45± 1.72 Group 0.437
T× G 0.239
Physical function T 17.42± 7.76 13.67± 9.49 Time 0.002**
T+E 23.15± 13.05 14.54± 10.87 Group 0.400
T× G 0.174
Total T 24.92± 10.21 19.08± 12.38 Time 0.001**
T+E 32.69± 17.44 20.23± 14.48 Group 0.391
T× G 0.163
Values are presented as mean± standard deviation.
VAS, visual analogue scale; WOMAC, Western Ontario and MacMaster; T, Thera-
curmin intake; T+E, Theracurmin with exercise.
**P< 0.01. ***P< 0.001.
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Table 5. The changes of balance after treatment
Variable Group Pre Post Sig
More-pain site
One-leg with open eyes (sec) T 53.47± 14.98 54.38± 13.13 Time 0.470
T+E 53.21± 14.89 57.71± 8.27 Group 0.684
T× G 0.630
One-leg with closed eyes (sec) T 8.37± 7.47 17.85± 16.79 Time 0.139
T+E 11.73± 15.53 14.73± 19.22 Group 0.979
T× G 0.434
COP with open eyes (mm) T 2,113.49± 295.29 1,392.79± 423.50 Time 0.006**
T+E 1,766.78± 826.30 1,557.48± 736.27 Group 0.666
T× G 0.106
COP with closed eyes (mm) T 1,483.45± 1,750.88 958.32± 1,409.48 Time 0.002**
T+E 694.34± 855.78 467.68± 441.16 Group 0.186
T× G 0.181
Less-pain site
One-leg with open eyes (sec) T 55.89± 12.46 54.78± 11.11 Time 0.447
T+E 52.59± 18.44 58.39± 5.79 Group 0.970
T× G 0.265
One-leg with closed eyes (sec) T 13.32± 17.02 10.72± 9.28 Time 0.912
T+E 13.32± 15.91 17.06± 19.06 Group 0.508
T× G 0.458
COP with open eyes (mm) T 1,973.89± 399.00 1,674.17± 476.55 Time 0.090
T+E 1,754.58± 722.93 1,583.29± 642.03 Group 0.423
T× G 0.635
COP with closed eyes (mm) T 1,166.72± 1,043.09 397.59± 220.48 Time 0.002**
T+E 952.79± 1,011.25 372.33± 378.48 Group 0.608
T× G 0.639
Values are presented as mean± standard deviation.
COP, centers of pressure; T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01. 
Table 6. The changes of walking after treatment
Variable Group Pre Post           Sig
10-M walking
Speed (sec) T 7.42± 0.74 6.72± 0.76 Time 0.000***
T+E 7.04± 0.75 6.509± 0.80 Group 0.309
T× G 0.478
Gravity (N) T 618.17± 50.81 610.50± 61.58 Time 0.008**
T+E 628.77± 67.60 602.38± 65.13 Group 0.959
T× G 0.126
Stair ascending & descending
Ascending (sec) T 4.71± 1.05 4.63± 0.83 Time 0.000***
T+E 4.13± 0.72 4.14± 0.72 Group 0.909
T× G 0.697
Descending (sec) T 4.32± 0.88 6.32± 9.37 Time 0.631
T+E 4.35± 1.33 3.65± 0.67 Group 0.326
T× G 0.321
Values are presented as mean± standard deviation.
T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01. ***P< 0.001.
RESULTS
The changes in body composition
Table 2 shows the changes in body composition after 4 weeks of 
Theracurmin and exercise. BW and BMI were not significantly 
different. Muscle mass was significantly increased (P<0.05), and 
the percent body fat was significantly decreased (P<0.05) after 
treatment. There was no correlation between time and group.
The changes in pain score
Table 3 shows the changes in pain score after 4 weeks of Thera-
curmin and exercise. The VAS was significantly decreased after 4 
weeks (P<0.001). WOMAC score was significantly decreased in 
pain (P<0.001), physical function difficulties (P<0.01), and total 
score (P<0.01). There was no correlation between time and group.
The changes in ROM of the knee
Table 4 shows the changes in ROM of the knee after 4 weeks of 
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Table 7. The changes of isokinetic strength after treatment
Variable Group Pre Post Sig
More-pain site
   Flexion
Peak torque (Nm) T 29.58± 8.12 37.33± 9.84 Time 0.000***
T+E 30.75± 14.51 40.50± 17.42 Group 0.666
T× G 0.608
Work (Watt) T 156.67± 47.21 184.08± 53.25 Time 0.001**
T+E 156.67± 85.26 200.67± 95.29 Group 0.933
T× G 0.214
   Extension
Peak torque (Nm) T 68.75± 14.96 75.42± 14.30 Time 0.001**
T+E 70.25± 22.49 75.42± 23.68 Group 0.843
T× G 0.980
Work (Watt) T 361.33± 84.89 375.50± 69.52 Time 0.005**
T+E 349.25± 151.45 415.67± 136.77 Group 0.760
T× G 0.057†
Less-pain site
   Flexion
Peak torque (Nm) T 28.83± 7.22 35.67± 9.70 Time 0.000***
T+E 28.83± 17.22 37.92± 19.51 Group 0.651
T× G 0.773
Work (Watt) T 152.92± 42.17 178.00± 46.75 Time 0.001**
T+E 162.75± 100.26 196.25± 105.89 Group 0.660
T× G 0.594
   Extension
Peak torque (Nm) T 75.00± 17.37 81.25± 18.42 Time 0.000***
T+E 90.08± 82.76 106.92± 99.05 Group 0.454
T× G 0.075
Work (Watt) T 388.92± 88.20 384.33± 85.06 Time 0.102
T+E 347.33± 152.39 409.67± 120.23 Group 0.854
T× G 0.061†
Values are presented as mean± standard deviation.
T, Theracurmin intake; T+E, Theracurmin with exercise.
**P< 0.01. ***P< 0.001. †Trend for significant.
Theracurmin and exercise. The angle of flexion and extension in 
more-pain site and less-pain site was decreased after 4 weeks (P< 
0.001), however there was no correlation between time and group.
The changes in balance
Table 5 shows the changes in balance after 4 weeks of Theracur-
min and exercise. The time of one leg standing with and without 
eyes closed was not significantly different in more-pain site, COP 
with closed eye was decreased after 4 weeks (P<0.01). COP with 
closed eye in less-pain site was significantly decreased after 4 weeks 
(P<0.01).
The changes in walking 
Table 6 shows the changes in walking after 4 weeks of Thera-
curmin and exercise. 10-m walking speed (P<0.001), gravity 
(P<0.01), and stair ascending speed (P<0.001) were significantly 
decreased after treatment.
The changes in isokinetic strength 
Table 7 shows the changes in isokinetic strength after 4 weeks 
of Theracurmin and exercise. The muscle strength of more-pain 
site was significantly increased for peak torque and total work for 
both flexion and extension (P<0.01). Total work in extension shows 
correlation between time and group (P=0.057). The muscle strength 
https://doi.org/10.12965/jer.1735064.532
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of less-pain site was significantly increased for peak torque (P<0.001), 
total work in flexion (P<0.01), and peak torque in extension (P< 
0.001). The total work in extension shows correlation between time 
and group (P=0.061).
DISCUSSION
This study was investigated the Theracurmin intake in con-
junction with exercise effects on pain, muscular function and daily 
living functions in osteoarthritis patients. The results showed that 
both T and T+E groups showed improvements on all the investi-
gated elements, and the difference between groups only observed 
in the total work amount during extension of the muscle. 
The major symptoms for osteoarthritis patients are pain, and 
joint stiffness that decreases movement caused by limits the pa-
tient’s capacity for daily activities (Altman, 1991). Therefore, the 
priority for the symptom management of osteoarthritis patients 
must be pain control via drug treatment or nondrug treatment 
(Bruyère et al., 2014; Fernandes et al., 2013; McAlindon et al., 
2014). However, because current long-term drug treatments can 
have side effects, most studies conducted on disease modifying 
agents. Curcumin is one such disease-modifying agent and known 
to have an anti-inflammatory property that suppresses prostaglan-
din synthesis by affecting cyclooxygenase, an enzyme important 
for converting arachidonic acid to prostaglandins (Rao, 2007). It 
has been reported that curcumin is a catabolic mediator that in-
hibits inflammation by suppressing nuclear factor-kappa B activa-
tion, a key event in chronic inflammatory response (Buhrmann et 
al., 2010). In this study, pain score (VAS scale) as well as pain, 
function, and total scores in the WOMAC score were decreased in 
both, the T and T+E groups with a 4-week intake of Theracur-
min, which has a 27-fold increased physiologic activity compared 
to curcumin. Although there was no significant improvement 
shown in joint stiffness in WOMAC score, the range of motion of 
the knee joint improved in both flexion and extension.
It proposed that these positive changes were the result of the ef-
fect of Theracurmin intake that reduced pain and discomfort from 
osteoarthritis. Furthermore, aerobic and weight exercise is one of 
the most strongly recommended treatments among the nondrug 
treatment options for osteoarthritis (Hochberg et al., 2012), and 
has been shown to be effective in decreasing discomfort due to the 
pain of osteoarthritis (Juhl et al., 2014). Therefore, use of both 
Theracurmin and exercise can be propose to be effective in de-
creasing pain and enhancing joint function. 
According to previous studies, pain due to osteoarthritis and 
joint movement disorders seem to cause reduction in muscular 
strength of quadriceps femoris muscle as well as loss of sensation 
and proprioception (Hassan et al., 2001; Wegener et al., 1997). 
Balance is a collaborative response of maintaining sensory infor-
mation transmitted from vestibular organs and visual and somato 
sensory organs through neurologic and muscular response from 
the central nerve system (Koceja et al., 1999), and reduction in 
proprioception for osteoarthritis patients can limit physical activi-
ties such as walking or balancing (van der Esch et al., 2007). As a 
result of Theracurmin intake with and without exercise for 4 weeks, 
there was no increase in the time for standing on one foot, but the 
degree of shaking in the center of gravity while standing on one 
foot both, with eyes open and closed had significantly improved. 
In addition, the performance in the 10-m walking test and while 
walking up the stairs improved. This suggests that the Theracur-
min and exercise treatments helped decrease shaking of the pa-
tient’s center of gravity by reducing pain. In addition, the reduced 
pain effect to increase the daily steps during the 4 weeks of treat-
ment, thereby enhancing the capabilities of the 10-m walk and 
walking up the stairs. However, improvements in movement and 
walking ability were equivalent in both groups of Theracurmin 
only and Theracurmin with exercise. This was likely because the 
treatment period was relatively short to reveal the effect of exer-
cise, and because both groups showed increased daily steps. 
It has been reported that pain in the knee joint also affects mus-
cular strength. Messier et al. (2002) reported that the muscular 
strength of the quadriceps femoris muscle is lower in a group of 
patients with chronic pain than in a group of patients without 
chronic pain. It has also been reported that when pain in the knee 
joint is decreased using local anesthetics quadriceps femoris mus-
cular strength is significantly increased (Hassan et al., 2002). Kim 
et al. (2013) reported that a significant difference was seen when 
comparing more pain sites and less pain sites for knee joint exten-
sion but not for knee joint flexion. In this study, in terms of mus-
cular strength, both, the peak torque and total work improved in 
flexion and extension; the T+E group displayed more improve-
ment than the T group during extension, showing correlation be-
tween the group and the treatment. On lesser pain sites, both, the 
peak torque and total work increased during flexion, but only the 
peak torque increased during extension, and the total work in-
creased in only the T+E group, with group treatment correlation 
as demonstrated in the previous studies. 
Pain in the knee joint causes reflex muscle inhibition that makes 
pushing the isokinetic instrument more difficult during the mus-
cular strength measurement, decreases the activity of the quadri-
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ceps femoris muscle, and therefore weakens the extension muscle 
(Sahin et al., 2008). Therefore, we propose that pain reduction of 
the knee joint from Theracurmin intake must have caused an in-
crease in muscular strength. In addition, it has been reported that 
aerobic exercise and weight training for the quadriceps femoris 
muscle are effective in decreasing pain and movement disorder of 
osteoarthritis patients (Juhl et al., 2014). We propose that T+E 
exercise group showed more improvements than T group caused 
by aerobic exercise and weight training is strengthen the quadri-
ceps femoris, hamstring muscle, and triceps muscle of calf.
In conclusion, the 4-week intake of Theracurmin with and with-
out exercise appeared to be effective in reducing the pain and en-
hancing muscular and balancing function. Although no difference 
observed between the two groups except for muscular strength, 
the effects of exercise depend on its intensity and duration. In ad-
dition, as reported previously, the longer the exercise period, high-
er the improvement (Fernandes et al., 2013). Therefore, increasing 
the exercise period duration would expected to further alleviate 
the symptoms of osteoarthritis compared to Theracurmin intake 
without exercise. Therefore, Theracurmin intake for early symp-
toms and additional exercise as symptoms alleviate might be an 
effective way of delaying and managing osteoarthritis, and addi-
tional studies investigating the effects of Theracurmin and exer-
cise on osteoarthritis could be beneficial.
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